A Combination of Approved Drugs Enhances the Delivery of Anti-Bacterial Medications to Treat Tuberculosis
Findings from an animal model indicate that bevacizumab and losartan can help drugs target hard-to-reach tuberculosis bacteria.
Research at Massachusetts General Hospital includes multitude of hospital-wide centers, institutes and programs as well as collaborations with other institutions.
Findings from an animal model indicate that bevacizumab and losartan can help drugs target hard-to-reach tuberculosis bacteria.
The study was designed to compare four major medications approved by the FDA to treat diabetes in combination with metformin, the usual first-line drug.
Results warrant additional studies into the health benefits of aspirin for patients with metabolic dysfunction–associated steatotic liver disease.
It’s fitting that the investigators who developed a new CAR T-based treatment for glioblastoma called their treatment platform “CAR-TEAM” cells, as it took a true team effort to bring their concept from the lab to the clinic.
The U.S. ranked 13th of 45 countries in advocating for and supporting these individuals’ wellbeing.
Jonathan Chen, MD, PhD, and Nir Hacohen, PhD, are co-authors of a recently published study in Nature Immunology, Human Lung Cancer Harbors Spatially-organized Stem-immunity Hubs Associated with Response to Immunotherapy.